Crescent Biopharma, Inc.
CBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001253689
In the last 90 days, Crescent Biopharma, Inc. insiders filed 1 open-market purchase and 7 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $532.6M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Crescent Biopharma, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 49
- −6 vs. Q2 2023
- Shares held
- 34.7M
- −864.9K (−2.4%) vs. Q2 2023
- Total value
- $52.1M
- −$9.84M (−15.9%) vs. Q2 2023
- New holders
- 5
- 8 more added
- Sold out
- 11
- 18 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $532.6M |
| Q1 2026 | 63 | $476.6M |
| Q4 2025 | 58 | $285.9M |
| Q3 2025 | 41 | $134.6M |
| Q2 2025 | 30 | $173.5M |
| Q1 2025 | 35 | $6.46M |
| Q4 2024 | 41 | $7.56M |
| Q3 2024 | 36 | $3.00M |
| Q2 2024 | 35 | $7.20M |
| Q1 2024 | 69 | $110.5M |
| Q4 2023 | 58 | $82.8M |
| Q3 2023 | 49 | $52.1M |
| Q2 2023 | 55 | $61.9M |
| Q1 2023 | 54 | $46.6M |
| Q4 2022 | 48 | $83.3M |
| Q3 2022 | 35 | $14.3M |
| Q2 2022 | 37 | $15.8M |
| Q1 2022 | 44 | $31.2M |
| Q4 2021 | 47 | $42.7M |
| Q3 2021 | 48 | $64.9M |
| Q2 2021 | 58 | $72.5M |
| Q1 2021 | 78 | $110.4M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Crescent Biopharma, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Signaturefd, LLC | 100 | $150 | 0.00% | +100 | New |
| Barclays PLC | 152 | $228 | 0.00% | +76+100.0% | Added |
| Wells Fargo & Company | 357 | $536 | 0.00% | −18−4.8% | Reduced |
| Qube Research & Technologies Ltd | 399 | $599 | 0.00% | +399 | New |
| JPMorgan Chase & Co | 466 | $699 | 0.00% | −323−40.9% | Reduced |
| BNP Paribas Arbitrage, SA | 481 | $722 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 1,044 | $1.57K | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 2,057 | $3.09K | 0.00% | 00.0% | Unchanged |
| Hartford Financial Management Inc. | 3,500 | $5.25K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,662 | $6.99K | 0.00% | −3,955−45.9% | Reduced |
| Bank of America Corp | 8,224 | $12.3K | 0.00% | +125+1.5% | Added |
| Creative Planning | 10,000 | $15.0K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 10,000 | $15.0K | 0.00% | 00.0% | Unchanged |
| Pine Valley Investments Ltd Liability Co | 12,520 | $18.8K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 13,000 | $19.5K | 0.00% | +3,000+30.0% | Added |
| Tobias Financial Advisors, Inc. | 15,000 | $22.5K | 0.01% | 00.0% | Unchanged |
| Chicago Partners Investment Group LLC | 20,000 | $23.4K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 19,967 | $29.9K | 0.00% | +19,967 | New |
| Charles Schwab Investment Management Inc | 22,361 | $33.5K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 24,875 | $37.3K | 0.00% | −234−0.9% | Reduced |
| Acuta Capital Partners, LLC | 27,500 | $41.3K | 0.03% | +27,500 | New |
| Group One Trading, L.P. | 28,401 | $42.6K | 0.00% | −25,738−47.5% | Reduced |
| XTX Topco Ltd | 32,722 | $49.1K | 0.01% | +2,724+9.1% | Added |
| Ieq Capital, LLC | 38,363 | $57.5K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 40,385 | $60.6K | 0.00% | −57,546−58.8% | Reduced |
| Dimensional Fund Advisors LP | 44,532 | $66.8K | 0.00% | 00.0% | Unchanged |
| Letko, Brosseau & Associates Inc | 45,250 | $67.9K | 0.00% | 00.0% | Unchanged |
| Sargent Investment Group, LLC | 58,000 | $87.0K | 0.02% | −50,000−46.3% | Reduced |
| Intellectus Partners, LLC | 61,975 | $93.0K | 0.03% | −11,500−15.7% | Reduced |
| Millennium Management LLC | 63,896 | $95.8K | 0.00% | −13,903−17.9% | Reduced |
| Gsa Capital Partners LLP | 93,785 | $141.0K | 0.01% | +93,785 | New |
| Franklin Resources Inc | 95,893 | $143.8K | 0.00% | −24,778−20.5% | Reduced |
| Northern Trust Corp | 106,236 | $159.4K | 0.00% | −14,637−12.1% | Reduced |
| Two Sigma Investments, LP | 114,072 | $171.1K | 0.00% | −75,656−39.9% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 149,106 | $223.7K | 0.00% | −7,085−4.5% | Reduced |
| Bridgeway Capital Management, LLC | 172,200 | $258.3K | 0.01% | +36,300+26.7% | Added |
| State Street Corp | 186,765 | $280.1K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 201,107 | $302.0K | 0.00% | +85,007+73.2% | Added |
| Two Sigma Advisers, LP | 219,000 | $328.5K | 0.00% | −232,102−51.5% | Reduced |
| Geode Capital Management, LLC | 459,845 | $690.0K | 0.00% | −16,395−3.4% | Reduced |
| BlackRock Inc. | 734,704 | $1.10M | 0.00% | −49,201−6.3% | Reduced |
| Goldman Sachs Group Inc | 794,494 | $1.19M | 0.00% | +10,763+1.4% | Added |
| Acadian Asset Management LLC | 844,051 | $1.26M | 0.01% | −305,605−26.6% | Reduced |
| AXA S.A. | 1,625,698 | $2.44M | 0.01% | −5,811−0.4% | Reduced |
| Vanguard Group Inc | 2,421,869 | $3.63M | 0.00% | +107,464+4.6% | Added |
| Octagon Capital Advisors LP | 3,000,000 | $4.50M | 0.79% | 00.0% | Unchanged |
| NEA Management Company, LLC | 4,764,440 | $7.15M | 0.55% | 00.0% | Unchanged |
| Artal Group S.A. | 8,589,064 | $12.9M | 0.56% | 00.0% | Unchanged |
| BVF Inc | 9,544,262 | $14.3M | 0.39% | 00.0% | Unchanged |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −142,400−100.0% | Sold out |
| Truist Financial Corp | 0 | $0 | 0.00% | −101,000−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −42,069−100.0% | Sold out |
| Stratos Wealth Partners, LTD. | 0 | $0 | 0.00% | −33,340−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −18,340−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −10,984−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −6,323−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −2,062−100.0% | Sold out |
| Impact Partnership Wealth, LLC | 0 | $0 | 0.00% | −575−100.0% | Sold out |
| Carolinas Wealth Consulting LLC | 0 | $0 | 0.00% | −395−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −167−100.0% | Sold out |